Cloning full-length large (S 3 kb) dsRNA genome segments from small amounts of dsRNA has thus far remained problematic. Here, a single-primer amplification sequence-independent dsRNA cloning procedure was perfected for large genes and tailored for routine use to clone complete genome sets or individual genes. Nine complete viral genome sets were amplified by PCR, namely those of two human rotaviruses, two African horsesickness viruses (AHSV), two equine encephalosis viruses (EEV), one bluetongue virus (BTV), one reovirus and bacteriophage Φ12. Of these amplified genomes, six complete genome sets were cloned for viruses with genes ranging in size from 0n8 to 6n8 kb. Rotavirus dsRNA was extracted directly from stool samples. Co-expressed EEV VP3 and VP7 assembled into core-like particles that have typical orbivirus capsomeres. This work presents the first EEV sequence data and establishes that EEV genes have the same conserved termini (5h GUU and UAC 3h) and coding assignment as AHSV and BTV. To clone complete genome sets, one-tube reactions were developed for oligo-ligation, cDNA synthesis and PCR amplification. The method is simple and efficient compared to other methods. Complete genomes can be cloned from as little as 1 ng dsRNA and a considerably reduced number of PCR cycles (22-30 cycles compared to 30-35 of other methods). This progress with cloning large dsRNA genes is important for recombinant vaccine development and determination of the role of terminal sequences for replication and gene expression.
Introduction
There are six virus families with dsRNA genomes, namely Birnaviridae, Cystoviridae, Hypoviridae, Partitiviridae, Reoviridae and Totiviridae. Several viruses of the family Reoviridae are aetiological agents for disease in humans and animals. Advances in recombinant DNA technology continue to raise expectations of generating a range of new vaccine candidates to combat infectious diseases. For diseases caused by viruses of the family Reoviridae, the key to tapping into this powerful technology is the ability to clone full-length dsRNA genes. In the case of the Rotavirinae and Orbivirinae, the main focus of our research, this requires cloning of dsRNA genes that are classified as large, namely genes of 3-4 kb (Sabara et al., 1991 ; Crawford et al., 1994 ; Brussow et al., 1990 ; McNeal et al., 1992 ; Madore et al., 1999 ; Roy et al., 1996 Roy et al., , 1990 ; MartinezAuthor for correspondence : Albie van Dijk.
Fax j61 2 6246 4173. e-mail albievandijk!hotmail.com Torrecuadrada et al., 1996 ; Stone-Marschat et al., 1996 ; du Plessis et al., 1998 ; Scanlen et al., 2002) . Although dsRNA cloning has progressed steadily, routine cloning of large dsRNA genes remains problematic, especially where dsRNA template is limited, e.g. in cases where viruses have not been cultured, or where no sequence information is available.
Difficulties and limitations of existing dsRNA cloning methods are as follows : the first dsRNA cloning methods based on polyadenylation of genomic dsRNA, oligo(dT)-primed reverse transcription, followed by blunt-ended cloning or dC-tailing and cloning into dG-tailed pBR322 (Cashdollar et al., 1982 (Cashdollar et al., , 1984 were generally technically complicated, the various steps were very inefficient and required relatively large amounts ( 1 µg) of dsRNA starting material. The homopolymeric tails of cloned genes presented difficulties for subsequent sequencing and expression. The second generation cloning procedures used PCR amplification of cDNA, which made it possible to clone from much smaller amounts of starting material. Initially, PCR-based procedures depended on the prior availability of flanking sequence information of the gene of interest. The conservation of termini within the different Reoviridae species allowed amplification of specific full-length cDNA of dsRNA genes using segment termini-specific primers (Kowalik et al., 1990 ; Cooke et al., 1991) . A milestone in dsRNA cloning was the development of a single-primer amplification sequence-independent method for rotaviruses that cannot be cultured (Lambden et al., 1992) . However, only dsRNA genes smaller than 1n5 kb could initially be cloned intact (Lambden et al., 1992 ; Bigot et al., 1995 ; James et al., 1999) . We reported progress in cloning large dsRNA genes when we cloned full-length 3-4 kb African horsesickness virus (AHSV) genome segments by extending the primer ligating to dsRNA with a poly(A) tail to facilitate oligo(dT) priming of poly(dA)-oligonucleotide-ligated dsRNA and by enriching oligo-ligated dsRNA for larger genome segments (Vreede et al., 1998) . However, this method, as well as the additional modifications to the single-primer amplification sequenceindependent method and other procedures reported recently (Attoui et al., 2000a ; Zhang & Rowhani, 2000 ; Chen et al., 2002) , are still not suitable for routine cloning of large, fulllength dsRNA genes and complete genome sets, since they require sequence data for segment-specific primers, need large amounts of dsRNA (at least 20 ng) per segment or hybridization screening of a library with segment-specific probes. Currently none of these methods can achieve the ultimate goal of amplifying a complete set of dsRNA genome segments of a dsRNA virus using one-tube reactions.
The objective of this investigation was to further develop and optimize the single-primer amplification sequence-independent dsRNA technique described by Lambden et al. (1992) for routine cloning of large dsRNA genes. We report here the use of our optimized technique in cloning full-length genes of complete dsRNA genome sets of six different viruses, each amplified in a one-tube PCR. We further demonstrate the use of the cloned genes in obtaining sequence information and recombinant protein expression. The ability to clone large dsRNA genes with ease is expected to speed up recombinant vaccine development initiatives and help to unravel the importance of terminal sequences for replication and gene expression of dsRNA viruses.
Methods
Viruses. AHSV serotypes 1 and 2, bluetongue virus (BTV) serotype 2, equine encephalosis virus (EEV) serotypes Bryanston and Kyalami (reference strains) and reovirus Dearing strain were obtained from the OIE Reference Laboratory at the Onderstepoort Veterinary Institute (Onderstepoort, South Africa). Bacteriophage Φ12 and its host (LM 2333) were obtained from Dr Paul Gottlieb (Sophie Davis School of Biomedical Education, New York, USA) and propagated as described by Mindich et al. (1999) . dsRNA preparation. dsRNA of the AHSV, BTV, EEV and reovirus was extracted from one 75 cm# flask of infected BHK cells. The dsRNA of bacteriophage Φ12 was extracted from phage purified from a 50 ml sloppy agar culture. The phage was purified from the agar suspension first by removal of the agarose and bacterial host by centrifugation at 8000 g. Phage was then purified from the supernatant by centrifugation at 25 000 r.p.m. (Beckmann JS-21) over a 40 % sucrose cushion. dsRNA from all these viruses was extracted using the commercial TRI-Reagent (Molecular Research Centre), according to the manufacturer's instructions, followed by precipitation with 2 M LiCl to remove ssRNA. The dsRNA was purified from the supernatant using a column from the Qiagen Gel Extraction kit. The human rotavirus dsRNA from the group A and C viruses was extracted directly from 600 µl of 10 % stool samples using TRI-Reagent.
Oligo-ligation and cDNA preparation.
] was ligated to a total of 1-700 ng dsRNA as described by Vreede et al. (1998) , with the exception that the reaction was incubated at 17 mC for 16 h. For amplification of specific individual genome segments, ligated dsRNA segments were separated by electrophoresis on either 1 % TBE or TAE agarose gels. Individual segments were excised and purified using the Gel Extraction kit. cDNA of the individual segments was prepared as described by Vreede et al. (1998) , without the incorporation of radioactive nucleotides. Removal of excess RNA, cDNA annealing and filling in of partial duplexes was carried out as described by Lambden et al. (1992) , except that cDNA hybridization was done for only 1 h at 65 mC. Amplification of cDNA was performed as described by Vreede et al. (1998) using primer PC2 (5h PO % -CCGAATTCCCGGGATCC-OH 3h), with the exception that Takara Ex Taq (Takara Shimadzu) was used as the DNA polymerase and only 22-30 cycles of PCR were performed, depending on the amount of starting material. The protocol for amplification of the whole genome in one PCR was similar except that the oligo-ligation reactions of the complete genomes were cleaned up using the Gel Extraction kit ; cDNA was prepared from all the genome segments in one cDNA reaction and the whole genomes were amplified in one tube, as described for single segments. For the amplification of the bacteriophage Φ12 genome, the incubation time at 72 mC was extended to 7 min.
Cloning and sequencing of amplified cDNA products. Amplified cDNA products were separated on a 1 % TAE agarose gel and individual segments were purified using the Gel Extraction kit. Restriction enzyme analyses of PCR products were performed to distinguish between segments that co-migrated on agarose gels. Purified PCR products were cloned into T\A cloning vectors pGEM-t (Promega) or pT-NOT (Franz & Dear, 1998) . Positive clones were identified on the basis of the size of the inserts. The clones with inserts from co-migrating cDNA segments were separated on the basis of their restriction enzyme profiles. The terminal ends of cDNA inserts were all sequenced with M13 forward and reverse primers using an ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction kit, version 2.0, on an ABI PRISM 377 DNA sequencer (Perkin-Elmer Applied Biosystems). Terminal sequences of the recombinants representing the different cloned genome sets were aligned using  (Lynnon Biosoft). Terminal sequences of AHSV-1, AHSV-2, BTV and rotavirus genes were compared with conserved terminal sequences from the same virus species from computerized databases using the  software program (NCBI) and those from bacteriophage Φ12 with sequences from partial and full-length clones obtained by Gottlieb et al. (2002a) .
Baculovirus expression.
The genes encoding the EEV-Kyalami proteins were cloned into either a quadruple baculovirus expression vector pBACgus4x-1 (Novagen) or a dual expression vector pFastBacDual (Life Technologies). The rotavirus VP6 gene was cloned into pFastBacHTb (Life Technologies). Recombinant viruses were prepared following the manufacturer's specifications. Proteins of cells infected with recombinant viruses were labelled with [$&S]methionine for 1 h at 72 h after infection. After labelling, the cells were harvested, washed twice in PBS and their total protein content was separated by SDS-PAGE and analysed by autoradiography. The dried radioactive gels were exposed overnight to Hyperfilm MP X-Ray film (Amersham Life Sciences). Core-like particles (CLPs) from cells infected with the dual baculovirus recombinant expressing EEV-Kyalami VP3 and VP7 were purified as described by Maree et al. (1998) . CLPs were stained with uranyl acetate prior to electron microscopy and photography at a magnification of 45 000.
Results dsRNA cloning
Previously, we reported improved cloning of large (4-2n8 kb) AHSV dsRNA segments 1, 2 and 3 using sucrosegradient centrifugation to separate them from the smaller genes prior to oligo-ligation (Vreede et al., 1998) . However, sucrose gradients could not be used for the enrichment of large genes from small amounts of starting material (100-700 ng of total RNA per genome) as used in this study. Therefore, agarose gel electrophoresis was investigated for separating genome segments. When cDNA was prepared from a pool of EEV-Bryanston dsRNA of segments 1, 2 and 3 and amplified by PCR (Fig. 1) , the yield of amplicons from segments 1 and 2 was low compared to that of segment 3 (Fig. 1, lane 5) . Both the yield of full-length cDNA and PCR amplicons of the largest genome segments increased significantly when individual agarose gel-purified oligo-ligated dsRNAs of the various genome segments were used. These PCR products could readily be cloned into T\A cloning vectors such as pGEM-t to yield full-length complete cloned virus genomes sets, such as that of AHSV-1 (Fig. 2) .
Surprisingly, it was found subsequently that the yield of PCR amplicons from agarose gel-purified dsRNA genome segments, either before or after oligo-ligation, was significantly lower than when oligo-ligation and cDNA synthesis was performed in one-tube reactions without fractionation of dsRNA or cDNA. Whether it was as a result of contaminating agarose inhibiting the enzyme reactions is not known. The yield of full-length PCR amplicons of the whole genome in a single tube improved the PCR amplicon yield of all segments to such an extent that only 22 cycles of PCR were needed for the amplification of the full-length genes of complete genomes of AHSV, BTV, EEV, reovirus and rotavirus (Fig. 3A) . When the number of PCR cycles was increased to more than 28, however, there was a bias favouring the yield of amplicons from medium and smaller segments compared to the yield of the large segments, as is evident for our human group C rotavirus cDNA (Fig. 3B, lane 2) .
Two further aspects were investigated to obtain an indication of the efficiency of the method. The first was to determine how efficient it would be for cloning from very small amounts of starting dsRNA and the second was to get an indication of the upper size limit of dsRNA that can be cloned. Fig. 1 . Agarose gel analysis of agarose gel-purified pools of oligo-ligated dsRNA of EEV-Bryanston and PCR products of cDNA derived from these pools. Lanes : 1, oligo-ligated dsRNA of the large segment pool ; 2, oligoligated dsRNA of the medium segment pool ; 3, oligo-ligated dsRNA of the small segment pool ; 4, PstI-digested λ DNA size marker ; 5, PCR products of the large segment pool ; 6, PCR products of the medium segment pool ; 7, PCR products of the small segment pool.
Amplification of an uncultured group C rotavirus from less than 1 ng of starting material in 30 amplification cycles yielded enough full-length amplicons of all the genes for cloning (Fig.  3B ). All three dsRNA genome segments of bacteriophage Φ12, family Cystoviridae, are large : 2n3, 4n1 and 6n8 kb, respectively (Mindich et al., 1999 ; Gottlieb et al., 2002b) . Amplification of the complete genome of bacteriophage Φ12 could be performed in a one-tube reaction in 25 cycles (Fig. 4A) . This was used to clone the entire genome (Fig. 4B) .
The molecular mass of all the various PCR products correlated either with that of the genes of published sequences (AHSV, BTV, reovirus and rotavirus) or with the molecular mass of their corresponding dsRNAs (EEV and Φ12). The amplified PCR products could be cloned into T\A cloning vectors such as pGEM-t or pT-NOT (Figs 2C and 4B) . Most cloned inserts could be gene-assigned based on their size. However, co-migrating segments, namely segments 7, 8 and 9 from AHSV, segments 7 and 8 from EEV and segments 3, 4 and 7, 8 and 9 of rotavirus were easily differentiated based on differences in their restriction enzyme profiles.
Sequencing of cloned genes
Sequencing of the terminal ends of the cloned genes was performed to establish whether these genes were full-length cDNA copies of the template dsRNA. The genes of AHSV-2 and rotavirus that we cloned here have not been previously cloned or sequenced. We determined that they have the same conserved terminal sequences as other viruses of their respective species (Table 1 ). The sequences of the terminal ends of our bacteriophage Φ12 genes (data not shown) were Fig. 2 . Cloning of a complete AHSV-1 genome set from individually purified genome segments. (A) Agarose gel analysis of purified oligo-ligated dsRNA of AHSV-1. Lanes : 1, PstI-digested λ DNA size marker ; 2, segment 1 dsRNA ; 3, segment 2 dsRNA ; 4, segment 3 dsRNA ; 5, segment 4 dsRNA ; 6, segment 5 dsRNA ; 7, segment 6 dsRNA ; 8, segments 7, 8 and 9 dsRNA (segments 7, 8 and 9 of AHSV-1 co-migrate on 1 % agarose gels) ; 9, segment 10 dsRNA. (B) Agarose gel analysis of PCR products from cDNA prepared from individually purified segments of oligo-ligated AHSV-1 RNA. Lanes : 1 and 10, PstIdigested λ DNA size marker ; 2, segment 1 PCR ; 3, segment 2 PCR ; 4, segment 3 PCR ; 5, segment 4 PCR ; 6, segment 5 PCR ; 7, segment 6 PCR ; 8, AHSV-1 segments 7, 8 and 9 PCR (segments 7, 8 and 9 of AHSV-1 co-migrate on 1 % agarose gels) ; 9, segment 10 PCR. (C) Agarose gel analysis of the complete genome of AHSV-1 cloned into pGEM-t and excised with SmaI. Lanes : 1, PstI-digested λ DNA size marker ; 2, segment 1 ; 3, segment 2 ; 4, segment 3 (pGEM-t and segment 3 have the same size and co-migrate) ; 5, segment 4 ; 6, segment 5 ; 7, segment 6 ; 8, segment 7 ; 9, segment 8 ; 10, segment 9 ; 11, segment 10. Lanes : 1 and 12, PstI-digested λ DNA size marker ; 2, total dsRNA of AHSV-2 ; 3, PCR amplicons of the complete AHSV-2 genome after 22 cycles of amplification ; 4, total dsRNA of BTV-2 ; 5, PCR amplicons of the complete BTV-2 genome after 22 cycles of amplification ; 6, total dsRNA of EEV-Bryanston ; 7, PCR amplicons of the complete EEV-Bryanston genome after 21 cycles of amplification ; 8, total dsRNA of a human group A rotavirus ; 9, PCR amplicons of the complete rotavirus group A genome after 25 cycles of amplification ; 10, total dsRNA of reovirus Dearing ; 11, PCR amplicons of the complete reovirus genome after 22 cycles of amplification. The amount of PCR amplicons of each virus represents the yield of PCR products from cDNA prepared from one-fifth of its respective dsRNA. (B) Agarose gel analysis of PCR products of cDNA prepared from 1 ng of total oligo-ligated dsRNA of a human group C rotavirus strain prepared in a one-tube reaction. The amplification was done in 30 PCR cycles. The dsRNA was not enough to be visible on an ethidium bromide-stained agarose gel. Lanes 1, PstI-digested λ DNA size marker ; 2, rotavirus C amplification products. Agarose gel analysis of purified bacteriophage Φ12 dsRNA and amplicons of cDNA prepared in a one-tube reaction. Lanes : 1, bacteriophage Φ12 dsRNA ; 2, full-length amplification products of cDNA prepared from oligoligated bacteriophage Φ12 dsRNA in 22 cycles of PCR amplification using the one-tube procedure ; 3, PstI-digested λ DNA size marker. (B) Agarose gel analysis of the complete genome of bacteriophage Φ12 cloned into pGEM-t and excised with SmaI. Lanes : 1, segment L ; 2 and 6, PstIdigested λ DNA size marker ; 3 and 4, segment M ; 5, a negative miniprep result ; 7, segment S.
the same as those obtained from the full and partial clones of this genome (Gottlieb et al., 2002a, b) . Terminal sequences of all the AHSV, BTV, reovirus and rotavirus genes revealed that all these genes were full-length cDNA copies of their cognate dsRNA templates. Although no sequence data are as yet available for EEV, our data that the non-coding terminal sequences of our cloned EEV genes were similar to the consensus terminal sequences of AHSV and BTV, lead us to conclude that they were full-length sequences. Inverted terminal repeats were identified on the gene segments encoding EEV VP6 and VP7 (Table 2) . We assigned our cloned EEV genes to their corresponding proteins by translating the 400-500 bp of sequence from both termini to amino acid sequences. The amino acid sequences were subjected to  Table 1 . Consensus terminal sequences of segments of the cloned genomes of AHSV-1, AHSV-2, EEV-Bryanston, EEV-Kyalami and a human group A rotavirus and known consensus sequences of viruses from the same species (where available)
Published sequences refer to sequences from the ICTV Virus Taxonomy Report (1997 analysis, which made it possible to assign all the genes, including the novel sequences of EEV, to their corresponding proteins. The coding assignment of the EEV genes correspond to that of AHSV and BTV (data not shown) except for the fact that the NS2 gene (segment 7) is slightly larger than the VP7 gene (segment 8). This could be seen after gel electrophoresis of the cDNAs of these two segments on a large agarose gel for an extended time period and full-length sequencing of the VP7 gene (1177 bp) (data not shown).
Baculovirus expression
To establish whether the open reading frames of the cloned genes could be translated to full-length functional proteins, the four newly cloned EEV-Kyalami genes (cloning data not shown) equivalent to the major structural proteins of BTV, namely the EEV VP2, VP3, VP5 and VP7 genes, were expressed using a baculovirus expression system. Co-expression of various combinations of recombinant EEV proteins as well as the single expression of rotavirus VP6 yielded proteins with the expected molecular mass (Fig. 5) . Coexpression of the EEV-Kyalami VP3 and VP7 proteins resulted in the intracellular accumulation of particles (Fig. 6) , which we concluded are EEV CLPs, since their size and morphology resembles that of native EEV cores and they have capsomeres typical of orbiviruses. 
Discussion
This paper describes the cloning of complete genome sets of a range of dsRNA viruses of the family Reoviridae, representing three different species, namely Reovirinae, Orbivirinae, Rotavirinae and one member of the family Cystoviridae, bacteriophage φ12, from as little as 1 ng and for genes up to 6n8 kb. Our successful cloning of large ( 3 kb) dsRNA genes finally perfects the original single-primer amplification sequence-independent cloning method and reaches the two ultimate goals for dsRNA cloning formulated by Lambden et al. (1992) . The first goal, that of being able to clone noncultivatable human rotavirus genomes directly from small clinical samples, was met by our cloning of two complete rotavirus genomes directly from stool samples, one from an uncultured human group A rotavirus and another from 1 ng starting material of a group C rotavirus. The second goal, namely that the method should be applicable without prior knowledge of any sequence information and generate fulllength cDNA clones of each genome segment, allowing unequivocal delineation of the 5h-and 3h-terminal gene sequences, was achieved by our cloning of two complete EEV genome sets. Agarose gel electrophoretic sizing and nucleic acid sequencing confirmed that the cloned genes were fulllength. The finding that proteins of the correct molecular mass were produced by baculovirus expression of five of the cloned genes, those of EEV Kyalami encoding the four major structural proteins, VP2, VP3, VP5 and VP7 and the human rotavirus group C gene encoding VP6 indicates that these genes have functional open reading frames. This report is the first on cloning of complete genome sets using one-tube amplification reactions. It is also the first report of cloning of full-length EEV genes and identification of their terminal sequences. The result that complete genome sets can now routinely be cloned from small amounts of starting material together with the recent progress in sequencing entire dsRNA genomes (Attoui et al., 2000a, b) means that dsRNA cloning and molecular characterization and analysis is now coming of age. It should be possible to begin delivering on many of the expectations that were envisaged for dsRNA viruses since the advent of molecular cloning.
There is no one single aspect that is the key to our success with cloning of large dsRNA genes. The progress is the result of a series of optimization and mixing and matching of some of the original procedures and incorporation of some additional and\or newer technologies and reagents. The important parameters for cloning large dsRNA genes include further optimization of the ligation reaction and the use of methylmercuric hydroxide for denaturing dsRNA instead of the more commonly used combination of heat and DMSO. The finding that it is important to avoid a PCR amplification bias for smaller products and that agarose gel electrophoresis was more efficient for fractionating oligo-ligated dsRNA genome segments than sucrose-gradient centrifugation, described by Vreede et al. (1998) , confirms recent results of Attoui et al. (2000a) . Other modifications included using a long distance, high fidelity polymerase and commercial ion-exchange columns. The most significant contribution our method for cloning of large dsRNA segments is that it is the first and only one with which complete genome sets can be cloned using a series of one-tube reactions. Eliminating the need for purification of individual dsRNA genome segments and cDNAs simplifies, speeds up and improves the efficiency of the cloning procedure significantly by avoiding the inevitable losses associated with purification and recovery of the various stages of cloning genes.
The genomes of all the viruses in this investigation could be amplified in one-tube PCRs (Figs 3 and 4A) as opposed to the need of other methods for individual purification of large ( 3 kb) dsRNA genes (Attoui et al., 2000a) . The genome of EEV-Bryanston was cloned from amplicons generated by 21 PCR cycles (Fig. 3A, lane 7) and that of bacteriophage Φ12, of which all three genome segments are 3 kb (Mindich et al., 1999) , was cloned from 25 PCR cycles (Fig. 4A) . The best other methods for cloning of large genome segments need at least 20 ng dsRNA per segment and 35 PCR cycles for amplification of full-length large segments ; these segments have to be purified individually and need to be 5h-methylated (Attoui et al., 2000a) . Lowering the number of PCR cycles significantly reduces the risk for PCR-induced mutations, especially for the larger genes and for cloning genes destined for expression, such as in recombinant vaccine initiatives and investigations on structure and function. We have not fully investigated the upper size limit of dsRNA genome segments that can be cloned. In a pilot experiment, we did not manage to clone a 13 kb chimaeric bacteriophage Φ6 genome (data not shown). We speculate that the range of the reverse transcriptase (5 kb is indicated by the manufacturer Promega) used could be the limiting factor.
Our main motivation for developing this cloning method was to facilitate recombinant vaccine development for rotaviruses and the orbiviruses, AHSV and BTV. The major protective antigens of these viruses and the genes that encode them have been identified, and proof of concept and the feasibility of developing recombinant subunit vaccines that induce protective, (sero)type-specific humoral immunity has been established (Sabara et al., 1991 ; Crawford et al., 1994 Crawford et al., , 1999 Brussow et al., 1990 ; McNeal et al., 1992 ; Madore et al., 1999 ; Roy et al., 1990 Roy et al., , 1996 Martinez-Torrecuadrada et al., 1996 ; Stone-Marschat et al., 1996 ; du Plessis et al., 1998 ; Scanlen et al., 2002) . The genes are all outer capsid proteins that determine (sero)type and induce neutralizing antibodies, namely rotavirus glycoprotein VP7 and spike protein VP4 and outer capsid protein VP2 of AHSV and BTV. Unfortunately, apart from rotavirus VP7 genes, all the genes fall in the 2-4 kb size range, which has thus far been difficult to clone. For rotavirus vaccine development, the progress reported here is particularly timely in view of the setback that the long awaited, new tetravalent rotavirus vaccine (RotaShield) introduced in 1998, a rhesus rotavirus background with three human VP7 genes incorporated by reassortment, had to be withdrawn after infants developed intussusception (McCarthy, 1999) . This setback resulted in the need for new rotavirus vaccine initiatives to explore various alternative options for developing vaccines.
Our cloned EEV genome represents the first complete set of intact, full-length genes and the terminal sequences the first nucleic acid sequence data generated for this virus species. The VP2 genes of AHSV-1 and -2 were not cloned previously and are important for recombinant vaccine development. The AHSV-1 and -2 and EEV-Bryanston and -Kyalami VP2 genes generated here will be slotted into recombinant subunit vaccine initiatives and new diagnostic methods for typing for the respective virus species, as described recently for AHSV and BTV (du Plessis et al., 1998 ; Scanlen et al., 2002 ; Koekemoer et al., 2000 ; Sailleau et al., 2000 ; Bremer et al., 1994 ; Cloete et al., 1994) . Our progress with routine cloning of large dsRNA genome segments will finally make it possible to develop complete recombinant VP2-based vaccine repertoires against all nine AHSV (van Dijk, 1999) and 24 BTV (van Dijk, 1993) serotypes, as well as for other orbiviruses, such as EEV, Palyam virus and Kemerovo virus. The prospect that it might be possible to generate recombinant vaccines directly from fully virulent isolates from field cases or directly from clinical samples that have not been cultured is particularly exciting and can now be investigated. If successful, it will create the opportunity to readily incorporate local strains and isolates in recombinant vaccines. This will constitute a workable alternative, especially for those viruses that have not been attenuated.
Partial nucleic acid sequence data obtained for each of the EEV genes revealed that, in line with what has been observed with other members of the family Reoviridae (Mertens et al., 2000) , all 10 segments of the EEV-Bryanston and -Kyalami genomes have conserved terminal sequences. We established that the EEV conserved terminal bases (5h GUU and UAC 3h) are identical to those of AHSV and BTV. The coding assignments of the EEV genes could be deduced from the partial 5h-and 3h-terminal coding nucleic acid sequences obtained in the process of characterizing the terminal ends and compared to orbivirus sequences in the databases (data not shown). EEV has the typical protein complement and coding assignment of AHSV and BTV except for segments 7 and 8, which are reversed and encode NS2 and VP7, respectively. The coding assignment confirmed deductions made by earlier hybridization experiments that showed that partial clones of EEV genome segments 3, 8 and 10 were highly conserved and a partial genome segment 2-specific probe did not hybridize with dsRNA from any of the other EEV serotypes, suggesting that this segment encodes the serotype-specific antigen of EEV (Viljoen & Huismans, 1989) . Segment-specific inverted terminal repeats were identified for EEV genome segments encoding VP7 and VP6 (Table 2 ). These conserved motifs have been postulated to act as sorting signals during replication for packaging plus-sense ssRNA of each genome segment into the progeny viral capsids (Anzola et al., 1987 ; Xu et al., 1989) and to interact by homologous base pairing, holding RNA transcripts in a panhandle structure that might guide the RNAdependent RNA polymerase (Attoui et al., 1997 (Attoui et al., , 1998 . Baculovirus expression of a few selected genes cloned in this study demonstrated that these cloned genes have functional open reading frames. The baculovirus-expressed rotavirus VP6 had the expected molecular mass and EEV-Kyalami VP3 and VP7 assembled into CLPs. The assembled EEV CLPs are envisaged to serve as a scaffold for attaching outer capsid proteins in vaccine development approaches similar to what has been done for BTV (Roy et al., 1994) and rotavirus (Madore et al., 1999) and for morphogenesis studies.
The progress reported in this paper for cloning large dsRNA genes, together with recent advances in full genome set sequencing for dsRNA genomes (Attoui et al., 2000a) , is expected to introduce a powerful new era in Reoviridae research and advance application of molecular knowledge in vaccine development, diagnostics, treatment and epidemiology. Extensive cloning and sequencing investigations can now all be initiated to unravel the importance of the terminal ends of dsRNA genome segments for replication and expression of genes of viruses of the family Reoviridae and form a basis for the development of reverse genetic systems for many of these viruses.
